Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

被引:18
|
作者
Fléchon, A
Rivoire, M
Biron, P
Droz, JP
机构
[1] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[2] Ctr Leon Berard, Dept Surg, F-69373 Lyon, France
来源
JOURNAL OF UROLOGY | 2001年 / 165卷 / 06期
关键词
germinoma; testes; mediastinum; drug therapy; salvage therapy;
D O I
10.1016/S0022-5347(05)66243-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The survival of patients with germ cell cancer after failed high dose chemotherapy is poor. We retrospectively reviewed the various treatment choices in this situation. Materials and Methods: From March 1986 to July 1996, 32 patients had disease progression after high dose cisplatin based chemotherapy plus hematopoietic stem cell support. Patients received high dose chemotherapy in the first line (11) or salvage (21) setting. Results: There was relapse after a complete or partial marker negative response after high dose chemotherapy in 19 cases at a median time to disease progression of 7 months (range 1.5 to 72). Salvage treatment involved chemotherapy alone in 5 cases, chemotherapy plus surgery in 6, surgery plus radiotherapy in 3, surgery alone in 2, combined radiotherapy, chemotherapy and surgery in 1, and no treatment in 1 due to a rapid disease course. The most common chemotherapy regimen was combined vinorelbine, ifosfamide and epirubicin. Eight patients achieved a complete response with the resection of all residual disease. At long-term followup 2 patients have been continuously disease-free for 84 and 109 months, respectively. After high dose chemotherapy 13 patients had evidence of disease, including 4 with a partial marker positive response and 9 with progressive disease. Salvage treatment involved chemotherapy plus surgery in 6 cases, chemotherapy alone in 2, no treatment in 2, and radiotherapy plus chemotherapy, radiotherapy alone and surgery alone in 1 each. One patient with progressive disease and 3 with a partial marker positive response achieved a complete response after salvage surgery, and combined surgery and high dose chemotherapy, respectively. These 4 patients have been continuously free of disease for 105, 95, 92 and 72 months, respectively. Conclusions: Six of the 32 patients with relapse or progressive disease after high dose chemotherapy have been free of disease in the long term. The most effective treatment was the resection of all residual masses. Chemotherapy had only marginal activity and the efficacy of radiotherapy seems to have been nil.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 50 条
  • [31] Indications for salvage surgery during treatment for intracranial germ cell tumors
    Masayuki Kanamori
    Toshihiro Kumabe
    Mika Watanabe
    Masashi Chonan
    Ryuta Saito
    Yoji Yamashita
    Yoshikazu Ogawa
    Yukihiko Sonoda
    Teiji Tominaga
    Journal of Neuro-Oncology, 2018, 138 : 601 - 607
  • [32] Indications for salvage surgery during treatment for intracranial germ cell tumors
    Kanamori, Masayuki
    Kumabe, Toshihiro
    Watanabe, Mika
    Chonan, Masashi
    Saito, Ryuta
    Yamashita, Yoji
    Ogawa, Yoshikazu
    Sonoda, Yukihiko
    Tominaga, Teiji
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (03) : 601 - 607
  • [33] Sexual functions after high-dose chemotherapy in survivors of germ cell tumors
    M Monti
    G Rosti
    U De Giorgi
    G Cavallari
    G Severini
    P Giovanis
    M Marangolo
    Bone Marrow Transplantation, 2003, 32 : 933 - 939
  • [34] Sexual functions after high-dose chemotherapy in survivors of germ cell tumors
    Monti, M
    Rosti, G
    De Giorgi, U
    Cavallari, G
    Severini, G
    Giovanis, P
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2003, 32 (09) : 933 - 939
  • [35] Salvage treatment for germ cell cancer after failed high-dose therapy
    Shamash, J
    Asterling, S
    Oliver, RTD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 787 - 788
  • [36] Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours
    El-Helw, L
    Coleman, RE
    CANCER TREATMENT REVIEWS, 2005, 31 (03) : 197 - 209
  • [37] High-dose chemotherapy in germ-cell tumors
    Droz, JP
    Culine, S
    Biron, P
    Kramar, A
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 997 - 1003
  • [38] Combination salvage chemotherapy for refractory germ cell tumors
    Nature Clinical Practice Urology, 2007, 4 (3): : 119 - 119
  • [39] Salvage chemotherapy in patients with recurrent germ cell tumors
    Foldyna, M.
    Abrahamova, J.
    Nepomucka, J.
    Donatova, Z.
    Vorilkova, E.
    Kordikova, D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 309 - 309
  • [40] SALVAGE CHEMOTHERAPY FOR REFRACTORY GERM-CELL TUMORS
    VOGELZANG, NJ
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 471 - 471